ArticleCardiovascular drugs and therapy2013

Incretin based therapeutics: connections to vascular biology and implications for potential cardiovascular disease prevention: Editorial to: "Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation" by Dai et al.

Anthony E DearPubMed ↗Publisher ↗

No numbers read from the abstract.